Abstract
Concepts concerning breast cancer have been considerably modified during the last 10 years. From the concept of a local disease with secondary metastases, the thinking has changed to that of a two-component disease: local on the one hand, and generalized on the other, the latter being more critical the larger the tumor size, the faster the tumor growth rate, the greater the lymph node involvement, and the less the differentiation on histological or nuclear grading.
Supported by INSERM and C. R. A. C. (Centre de Recherches Appliquées á la Chimiothérapie).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bonadonna G, Valagussa P (1985) Adjuvant systemic therapy for resectable breast cancer. Clin Oncol 3 (2): 259–275
Calle R, Pilleron JP (1979) Radiation therapy for operable breast cancer. 10 years results. Breast 5: 2–6
Canellos GP (1984) The treatment of locally advanced breast cancer. Clin Oncol 2 (3): 149–151
Chauvergne J, Durand M, Hoerni B, Cohen P, Lagarde C (1979) La chimiothérapie d’induction dans les cancers du sein à haut risque: Résultats d’une étude thérapeutique prospective. Bull Cancer (Paris) 66: 9–16
Ferguson DJ, Meier P, Karrison J, Dawson PJ, Straus FH, Lowenstein FG (1982) Staging of breast cancer and survival rates. JAMA 248: 1337–1341
Fisher B, Redmond C, Eias G, Evans J et al. (1982) Adjuvant chemotherapy of breast cancer: an overview of NSABP findings. Adv Surg Oncol 5: 65–90
Goldie JH, Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727–1733
Jacquillat C, Baillet F, Auclerc G et al. (1982) Initial chemotherapy and conservative radiotherapy in stage I, II and III breast cancer. Proceedings 13th International Cancer Congress, Seattle, pp 52 (abstract 3218)
Jacquillat C, Baillet F, Blondon J et al. (1983) Preliminary results of “neo-adjuvant” chemotherapy in initial management of breast cancer (BC). Proceedings ASCO, San Diego, 112 (abstract C 437)
Jacquillat C, Baillet F, Auclerc G et al. (1984a) Cancer du sein: chimiothérapie précédant le traitement loco-régional avec extension des indications du traitement conservateur. Bull Cancer (Paris) 71 (4): 354–360
Jacquillat C, Auclerc G, Baillet F et al. (1984b) Chimiothérapie première dans le cancer du sein: Résultats préliminaires. Ann Med Interne (Paris) 135 4: 1–295
Jacquillat C, Weil M, Auclerc G et al. (1985) Neoadjuvant chemotherapy in the conservative management of breast cancer. Study on 205 patients. Proc 1st Int Congress on neoadjuvant chemotherapy. Libbey, Paris
Jacquillat C, Baillet F, Weil M et al. (1988) Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation. Cancer 61: 1977–1982
Kantarjian HP, Hortobagyi GN, Smith TL, Blumenschein GR, Montague E, Buzdar AU, Martin RG (1984) The management of locally advanced breast cancer, a combined modality approach. Eur J Cancer Clin Oncol 20: 1353–1361
Karrer K, Humphreys SR, Goldin A (1967) An experimental model for studying factors which influence metastases of malignant tumors. Int J Cancer 2: 213
Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norin T (1978) Surgical adjuvant chemotherapy: results of one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 41: 2088–2098
Otmezguine Y, Martin A, Le Bourgeois JP, Maylin C, Raynal M, Sallé M, Pierquin B (1980) Etude des récidives parmi 202 cancéreuses du sein traitées conservativement par radiothérapie. J Eur Radiother 1: 115–130
Papaiannou AN (1981) Pre-operative chemotherapy for operable breast cancer. Eur J Cancer 17: 263–269
Rubens RD, Seston S, Tong D (1980) Combined chemotherapy and radiotherapy for locally advanced breast cancer. Eur J Cancer 16: 351–356
Schabel FM, Griswold DP, Corbett TH, Laster Jr, Dykes DJ, Rose WC (1979) Recent studies with adjuvant chemotherapy or immunotherapy of metastatic solid tumors of mice. In: Jones SE, Salmon SE (eds) Adjuvant therapy of cancer. Grune and Stratton, New York, pp 3–17
Tancini G, Bonadonna G, Valagussa P et al. (1983) Adjuvant CM F in breast cancer, comparative 5-year results of 12 versus 6 cycles. J Clin Oncol 1: 1–10
Zylberberg B, Salat-Baroux J, Ravina JH, Dormont D, Amiel JP, Dielbold P, Izrael V (1982) Initial chemoimmunotherapy in inflammatory carcinoma of the breast cancer 49: 1537–1543
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Jacquillat, C., Weil, M., Auclerc, G., Auclerc, MF., Khayat, D., Baillet, F. (1989). Neoadjuvant Chemotherapy in the Conservative Management of Breast Cancer: A Study of 252 Patients. In: Senn, HJ., Goldhirsch, A., Gelber, R.D., Osterwalder, B. (eds) Adjuvant Therapy of Primary Breast Cancer. Recent Results in Cancer Research, vol 115. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83337-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-83337-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83339-7
Online ISBN: 978-3-642-83337-3
eBook Packages: Springer Book Archive